Expert-Led Discourse on Treatment Strategies for Advanced HER2-Negative Gastric/GEJ Cancers

Learn strategies for incorporating immunotherapies and new molecularly targeted agents into the care of patients with advanced HER2-negative gastric/GEJ cancers with expert slides from a live webinar.

Share

Program Content

Activities

Therapy for Untreated HER2-Negative Advanced Gastric/GEJ Cancers
Initial Therapy for Previously Untreated Advanced HER2-Negative Gastric/GEJ Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2022

Expires: July 20, 2023

Previously Treated Advanced HER2-Negative Gastric/GEJ Cancers
Therapy for Previously Treated Advanced HER2-Negative Gastric/GEJ Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2022

Expires: July 20, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant

Astellas Pharma US